Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis
β Scribed by Gabriel Herrero-Beaumont; Olav Bjorneboe; Ute Richarz
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 270 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Transdermal fentanyl 75 micrograms/h (Fentanyl-TTS) was compared with placebo in a randomized double-blind study in the early postoperative period, using 50 patients recovering from major urological operations. Analgesic efficacy was individually titrated with intravenous fentanyl by means of a PCA
## Abstract ## BACKGROUND The delayed effects (12β16 hours) of transdermal fentanyl make dose titration difficult during acute exacerbations of cancer pain. Patients at the authors' institution routinely are switched from transdermal to intravenous (IV) fentanyl using a 1:1 (transdermal:IV) conver